VALUATION DIAGNOSTIC
Packaging (Medical / Pharma)
Specific market analysis for Packaging (Medical / Pharma) companies based in Lugano.
Pro-Forma Valuation
Market demand in Lugano for Packaging (Medical / Pharma) assets remains strong.
KEY DRIVER
"FDA/EMA validation moats, non-cyclical demand."
Local Multiples (Est.)
5.5 - 7.5x Statutory
Get Your Report
Generate a certified valuation for your Packaging (Medical / Pharma) business in Lugano.
Valuation Impact by Size (DACH 2025)
| Size Bucket | Multiple Range | Impact |
|---|---|---|
| Micro (< CHF 1M EBITDA) | 3.3x - 4.4x | -33.3% |
| Small (CHF 1M - 2M EBITDA) | 4.5x - 6.1x | -6.7% |
| Transition (CHF 2M - 5M EBITDA) | 5.5x - 7.5x | +11.1% |
| Lower Mid-Market (CHF 5M - 10M EBITDA) | 7.5x - 10.2x | +33.3% |
| Mid-Market (> CHF 10M EBITDA) | 9.5x - 12.9x | +66.7% |
Source: NIMBO, Dealsuite, KPMG, SECA, Practitioner Interviews // Niche Baseline: 6.5x
Packaging (Medical / Pharma) Market in Lugano
Lugano — known for a robust financial sector — represents a significant market for Packaging (Medical / Pharma) companies in Switzerland. The local business environment is shaped by the canton's economic profile, offering distinct opportunities for both buyers and sellers in this niche.
Current EBITDA multiples for Packaging (Medical / Pharma) businesses range from 5.5 - 7.5x (statutory) to 6.5 - 9.5x (deal), reflecting a moderate arbitrage opportunity. The sector trend is rising, driven by: FDA/EMA validation moats, non-cyclical demand. This positions Lugano as a notable market within the broader Industrial & Manufacturing sector.
Full Swiss market analysis across all 26 cantons, including comparable M&A transactions and sector trends.
Packaging (Medical / Pharma) Valuations Across Switzerland
Compare Packaging (Medical / Pharma) business valuation benchmarks in other Swiss cantons and cities.
Other Industries in Lugano
Explore valuation data for different sectors based in Lugano.